We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+12.27%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$59.8M
Cap. Flow
+$45.9M
Cap. Flow %
16.82%
Top 10 Hldgs %
63.91%
Holding
119
New
43
Increased
20
Reduced
8
Closed
21

Top Buys

Rank Stock Value
1
OVTI
OMNIVISION TECHNOLOGIES INC
OVTI
+$7.48M
2
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$3.85M
3
ISSI
INTEGRATED SILICON SOLUTN INC
ISSI
+$3.67M
4
GM icon
General Motors
GM
+$3.27M
5
GNTX icon
Gentex
GNTX
+$3.09M

Top Sells

Rank Stock Value
1
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
+$4.41M
2
PCYC
PHARMACYCLICS INC
PCYC
+$4.28M
3
HIMX
Himax Technologies
HIMX
+$3.38M
4
PTCT icon
PTC Therapeutics
PTCT
+$3.23M
5
BIDU icon
Baidu
BIDU
+$2.96M

Sector Composition

Rank Sector Weight
1 Healthcare 16.1%
2 Consumer Discretionary 6.86%
3 Technology 4.57%
4 Communication Services 3.05%
5 Industrials 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMX
101
Himax Technologies
HIMX
$2.23B
– –
-420,000
Closed -$3.38M
IPGP icon
102
IPG Photonics
IPGP
$3.7B
– –
-9,000
Closed -$674K
LITB
103
LightInTheBox
LITB
$58.9M
– –
-4,917
Closed -$185K
MDXG icon
104
MiMedx Group
MDXG
$622M
– –
-70,000
Closed -$807K
MEI icon
105
Methode Electronics
MEI
$499M
– –
-30,000
Closed -$1.09M
NBIX icon
106
Neurocrine Biosciences
NBIX
$16.7B
– –
-40,000
Closed -$894K
OSPN icon
107
OneSpan
OSPN
$588M
– –
-80,000
Closed -$2.26M
QQQ icon
108
PUT
Invesco QQQ Trust
QQQ
$469B
– –
-150,000
Closed -$15.5M
THRM icon
109
Gentherm
THRM
$1.28B
– –
-27,000
Closed -$989K
VNET
110
VNET Group
VNET
$2.04B
– –
-28,340
Closed -$438K
WMGI
111
DELISTED
Wright Medical Group Inc
WMGI
– –
-15,000
Closed -$403K
BITA
112
DELISTED
Bitauto Holdings Limited
BITA
– –
-27,000
Closed -$1.9M
ACHN
113
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-60,000
Closed -$735K
PCYC
114
DELISTED
PHARMACYCLICS INC
PCYC
– –
-35,000
Closed -$4.28M
ASPX
115
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
– –
-36,000
Closed -$1.89M
SIMG
116
DELISTED
SILICON IMAGE INC
SIMG
– –
-50,000
Closed -$276K
RNA
117
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
– –
-235,000
Closed -$4.41M
CCIH
118
DELISTED
Chinacache International Holdings Ltd
CCIH
– –
-12,960
Closed -$119K
DSKY
119
DELISTED
IDREAMSKY TECHNOLOGY LTD ADS REPTSG SHS CL A
DSKY
– –
-65,000
Closed -$1.11M
1 2 3 4
5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Granite Point Capital Management held 119 positions worth $273M, up 28% from $213M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Granite Point Capital Management deployed $45.9M of net new capital in Q1 2015, opening 43 new positions and adding to 20 existing holdings. Its largest new stake was INTEGRATED SILICON SOLUTN INC: 218,741 shares worth $3.91M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $3.23M trimmed.

  • Granite Point Capital Management's largest Q1 2015 buy was INTEGRATED SILICON SOLUTN INC: 218,741 shares worth $3.91M.
  • Granite Point Capital Management added most to OMNIVISION TECHNOLOGIES INC in Q1 2015, an estimated $7.48M increase.
  • Granite Point Capital Management's biggest Q1 2015 reduction was PTC Therapeutics, cutting an estimated $3.23M.
  • Granite Point Capital Management fully exited PROSENSA HLDGS N V ORD SHS (NLD) in Q1 2015, selling an estimated $4.41M.
  • Granite Point Capital Management's ten largest holdings make up 64% of its $273M portfolio in Q1 2015.
  • Granite Point Capital Management opened 43 new positions and closed 21 in Q1 2015.
  • Granite Point Capital Management's portfolio value rose 28% quarter-over-quarter to $273M.

Based on Granite Point Capital Management's 13F filing for Q1 2015, filed 14 May 2015.